Retatrutide 20mg + Trizepatide 40mg × 10 Vials

The Retatrutide + Tirzepatide complex is a groundbreaking research blend combining 20mg of Retatrutide (a Triple GIP/GLP-1/Glucagon receptor agonist) and 40mg of Tirzepatide (a Dual GIP/GLP-1 receptor agonist). This 60mg total concentration represents the apex of current metabolic pharmacology research. By integrating Retatrutide’s unique ability to engage the Glucagon receptor (GCGR) for thermogenesis and hepatic fat mobilization with Tirzepatide’s potent GHR and GLP-1 receptor synergy, this blend provides researchers with an unparalleled tool to study maximal energy expenditure, glucose homeostasis, and the mechanisms of non-linear fat oxidation.

With a verified chemical purity of ≥99%, this complex is free from isomeric impurities and residual reagents, ensuring high-fidelity results for studies involving insulin sensitivity and visceral adipose tissue (VAT) remodeling.

Compound: Retatrutide & Tirzepatide Blend (Advanced Metabolic Research)
Components: 20mg Retatrutide + 40mg Tirzepatide (Total 60mg Peptide)
Purity: ≥ 99% (Pharmaceutical Grade / HPLC & MS Tested)
Form: Sterile Solution (10ml Multi-Dose Vial) or Lyophilized Powder
Solubility: Ready-to-use Aqueous Solution (Pre-mixed)
Storage: 2-8°C (Short-term) | -20°C (Long-term / Up to 24 months)